Te­va CEO Kåre Schultz sees a 35% raise de­spite the com­pa­ny's con­tin­ued le­gal woes

Amid a year where revenues were mostly flat but lawsuits continued piling up, Teva CEO Kåre Schultz saw himself getting a raise.

In shareholder documents filed to the SEC on Wednesday, Teva revealed its executive compensation packages for 2020. Though his salary remained the same as each of the last two years, Schultz’s stock awards increased by about $4 million from 2019, accounting for almost all of the additional pay he received in his $15.7 million package.